Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 6/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.92 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.92 |
| ▸ | TSHR | P16473 | 3/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.92 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.80 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.71 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.71 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenanthrene SCHEMBL2321409 | 0.96 | ALDH1A1 (0.86) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL8873977 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL29358486 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL27458043 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL30932938 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL1330750 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL7643 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL29477074 | 0.96 | CYP2A6 (1.00) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL25318236 | 0.92 | CYP2A6 (0.92) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 | |
| Phenanthrene SCHEMBL6281749 | 0.92 | CYP2A6 (0.92) | CYP2A6ALDH1A1HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000022909-A2 | SYSTEMS FOR ORAL DELIVERY | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2000-04-27 | — | — | WO | claimed |
| JP-7133342-A | — | — | None | — | — | JP | disclosed |
| CN-117524324-A | Method for predicting twelve-molecule content in asphalt molecules to be detected | 大连理工大学 | 2024-02-06 | — | — | CN | disclosed |
| US-11856845-B2 | Compound | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2023-12-26 | — | — | US | disclosed |
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2023-08-15 | — | — | US | disclosed |
| CN-115364215-A | Platinum drug carbon nanodot and preparation method thereof, carbon nanodot protein complex and application | 澳门大学 | 2022-11-22 | — | — | CN | disclosed |
| US-11349084-B2 | Charge transfer salts and uses thereof | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2022-05-31 | — | — | US | disclosed |
| US-20220127285-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | disclosed |
| US-20210206911-A1 | POLYMER | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2021-07-08 | — | — | US | disclosed |
| US-11038147-B2 | Electroluminescence device | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20090238811-A1 | Enzymatic Antimicrobial and Antifouling Coatings and Polymeric Materials | REACTIVE SURFACES LTD. | 2009-09-24 | — | — | US | disclosed |
| US-20070145888-A1 | AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| US-20070129327-A1 | Blood flow promoters for cauda equina tissues | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| JP-H07133342-A | NEW POLYESTER AND ITS PRODUCTION | SEKIYU SANGYO KASSEIKA CENTER | 1995-05-23 | — | — | JP | disclosed |
| WO-1993004096-A1 | POLYMERS OF ACRYLAMIDOALKYL-SULPHONIC ACIDS | SIMON MEGSON LIMITED (GB) | 1993-03-04 | — | — | WO | disclosed |
| EP-0090475-B1 | MESOPHASE PITCH HAVING ELLIPSOIDAL MOLECULES AND METHOD FOR MAKING THE PITCH | UNION CARBIDE CORPORATION (US) | 1986-03-19 | — | — | EP | disclosed |
| US-4457828-A | COUPLING POLYMERIZATION OF CONDENSED RING AROMATIC HYDROCARBON | UNION CARBIDE CORPORATION (US) | 1984-07-03 | — | — | US | disclosed |
| US-4431513-A | USING A EUTECTIC MELT OF ALUMINUM TRICHLORIDE AND AN AMINE OR IMINE ACID SALT | UNION CARBIDE CORPORATION (US) | 1984-02-14 | — | — | US | disclosed |
| EP-0090475-A1 | Mesophase pitch having ellipsoidal molecules and method for making the pitch | UNION CARBIDE CORPORATION (US) | 1983-10-05 | — | — | EP | disclosed |
| US-4187369-A | Process for producing hydrocarbon-phenol-formaldehyde resin | FARBSHTEIN JURY G (SU) | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129327-A1 | Blood flow promoters for cauda equina tissues | PTGFR, PTGIS, PTGIR | CYP2A6 1015/4885ALDH1A1 427/4885HSD17B10 1440/4885 |
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CHRM1, SLC6A3, DRD1 | CYP2A6 4574/4885ALDH1A1 1969/4885HSD17B10 4449/4885 |
| US-11856845-B2 | Compound | NR0B2, CYP1B1, NR0B1 | CYP2A6 235/4885ALDH1A1 221/4885HSD17B10 500/4885 |
| US-20070145888-A1 | AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | EML4, TYR, ALKBH3 | CYP2A6 3610/4885ALDH1A1 692/4885HSD17B10 3706/4885 |
| US-20220127285-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | PIEZO1, LEF1, L1CAM | CYP2A6 1249/4885ALDH1A1 11/4885HSD17B10 2790/4885 |
| US-11349084-B2 | Charge transfer salts and uses thereof | SLC6A12, SLC43A3, GRN | CYP2A6 4885/4885ALDH1A1 4251/4885HSD17B10 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.